Faith Healing and Subtraction Anxiety - Rajkumar - Circ CQO 2018
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Circ</strong>ulation: Cardiovascular Quality <strong>and</strong> Outcomes<br />
CORRECTION<br />
Correction to: Moving the Goalposts Into Unblinded Territory:<br />
The Larger Lessons of DEFER <strong>and</strong> FAME 2 <strong>and</strong> Their Implications<br />
for Shifting End Points in ISCHEMIA [‘<strong>Faith</strong> <strong>Healing</strong>’ <strong>and</strong><br />
‘<strong>Subtraction</strong> <strong>Anxiety</strong>’ in Unblinded Trials of Procedures: Lessons<br />
from DEFER <strong>and</strong> FAME-2 for End Points in the ISCHEMIA Trial]<br />
In the article by <strong>Rajkumar</strong> et al, “Moving the Goalposts Into Unblinded Territory:<br />
The Larger Lessons of DEFER <strong>and</strong> FAME 2 <strong>and</strong> Their Implications for Shifting<br />
End Points in ISCHEMIA”, which published online on March 12, <strong>2018</strong> <strong>and</strong><br />
appeared in the March issue of the journal (<strong>Circ</strong> Cardiovasc Qual Outcomes<br />
<strong>2018</strong>;11:e004665. DOI: 10.1161/CIRCOUTCOMES.118.004665), we are making<br />
corrections in light of information provided by the ISCHEMIA trialists after the<br />
article was accepted.<br />
“It was on this basis that $84 million of United States National Heart, Lung, <strong>and</strong><br />
Blood Institute (US NHLBI) funding was awarded…” should read “Eighty-four million<br />
dollars of United States National Heart, Lung, <strong>and</strong> Blood Institute (US NHLBI)<br />
funding was awarded…”.<br />
“However, on January 17, <strong>2018</strong>, over 99% of the way through the recruitment<br />
period, an amendment was made to the clinicaltrials.gov website…”<br />
should be extended. It should read: “However, on January 17, <strong>2018</strong>, over 99%<br />
of the way through the recruitment period, 2 an amendment was made to the<br />
clinicaltrials.gov website. 3 This amendment indicated that the primary endpoint<br />
for ISCHEMIA had been altered to cardiovascular death, nonfatal MI, resuscitated<br />
cardiac arrest, or hospitalization for unstable angina or heart failure. The<br />
ISCHEMIA investigators have now detailed the steps involved in the change,<br />
which began in June 2017 after a recommendation from an NHLBI-appointed<br />
Independent Advisory Panel.” 1<br />
“… the primary end point that was pre-specified <strong>and</strong> not one that was postspecified”<br />
should read “…the primary end point of cardiovascular death or nonfatal<br />
MI. 3 ”<br />
“The trial closed to recruitment on January 31, <strong>2018</strong>, <strong>and</strong> is expected to report<br />
within the next few months. 2” should read “The trial closed to recruitment on<br />
January 31, <strong>2018</strong>. 2 ”<br />
“When the trial reports, we suggest that readers focus on the primary end<br />
point pre-specified not any versions edited near trial end when the great majority<br />
of events will have already accumulated.” should read “When the trial reports, we<br />
suggest that readers focus on the primary end point of cardiovascular death <strong>and</strong><br />
nonfatal MI that was originally pre-specified (which the ISCHEMIA trial will now<br />
report as a secondary endpoint).”<br />
“…we must reflect on whether there is any meaning to the term primary end<br />
point if these goalposts can be moved at will after a trial has begun recruiting—<br />
<strong>and</strong> especially if a very prominent trial does so shortly before reporting its result…”<br />
should read “…we must reflect on whether there is any meaning to the term<br />
primary end point when goalposts are moved after a trial has begun recruiting<br />
despite the best intentions of investigators.”<br />
© <strong>2018</strong> American Heart Association, Inc.<br />
http://circoutcomes.ahajournals.org<br />
<strong>Circ</strong> Cardiovasc Qual Outcomes. <strong>2018</strong>;11:e000038. DOI: 10.1161/HCQ.0000000000000038 April <strong>2018</strong> 1